HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

CAL 101

an antineoplastic agent; structure in first source
Also Known As:
CAL-101; CAL101
Networked: 18 relevant articles (5 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Xia, Bing: 2 articles (06/2015 - 10/2014)
2. Qu, Fulian: 2 articles (06/2015 - 10/2014)
3. Guo, Shanqi: 2 articles (06/2015 - 10/2014)
4. Zhang, Yizhuo: 2 articles (06/2015 - 10/2014)
5. Zhang, Qing: 2 articles (10/2014 - 04/2014)
6. Johnson, Amy J: 2 articles (01/2012 - 09/2010)
7. Byrd, John C: 2 articles (01/2012 - 09/2010)
8. Lannutti, Brian J: 2 articles (09/2011 - 09/2010)
9. Meng, Ling-hua: 1 article (10/2015)
10. Ding, Jian: 1 article (10/2015)

Related Diseases

1. Neoplasms (Cancer)
2. Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
3. Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
4. Multiple Myeloma
5. B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Related Drugs and Biologics

1. Phosphotransferases (Kinase)
2. bortezomib (Velcade)
3. celecoxib (Celebrex)
4. Small Interfering RNA (siRNA)
5. Protein Isoforms (Isoforms)
6. Ribosomal RNA
7. Phosphatidylinositols (Phosphatidylinositol)
8. 2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidine
9. IC 87114
10. rituximab (Mabthera)

Related Therapies and Procedures

1. Molecular Targeted Therapy